Analyst Reco. Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:30:36 15/05/2026 BST			5-day change	1st Jan Change
116.68 ^CHF	-0.10%		+2.98%	+6.46%

12:04pm	Health Rounds: Common ADHD medicines help treat cancer-related fatigue	RE
05-13	Wall Street Just Got Its Wholesale Receipt

05-05	NOVARTIS AG : JP Morgan reiterates its Buy rating	ZD
04-29	NOVARTIS AG : UBS sticks Neutral	ZD
04-29	NOVARTIS AG : Deutsche Bank reiterates its Buy rating	ZD
04-29	NOVARTIS AG : Goldman Sachs maintains a Sell rating	ZD
04-29	NOVARTIS AG : Barclays gives a Neutral rating	ZD
04-28	Novartis: Generic competition weighs on Q1 show
04-28	NOVARTIS AG : DZ Bank gives a Neutral rating	ZD
04-28	NOVARTIS AG : Bernstein gives a Neutral rating	ZD
04-28	NOVARTIS AG : UBS reiterates its Neutral rating	ZD
04-28	NOVARTIS AG : Barclays remains Neutral	ZD
04-28	NOVARTIS AG : Jefferies remains Neutral	ZD
04-27	AlphaValue/Baader Europe Upgrades Novartis to Add, Trims PT	MT
04-10	NOVARTIS AG : UBS reiterates its Neutral rating	ZD
03-31	NOVARTIS AG : Goldman Sachs remains a Sell rating	ZD
03-30	NOVARTIS AG : Deutsche Bank reiterates its Buy rating	ZD
03-27	NOVARTIS AG : Barclays is Neutral	ZD
03-24	NOVARTIS AG : Receives a Buy rating from Deutsche Bank	ZD
03-23	NOVARTIS AG : UBS is Neutral	ZD
03-23	BofA Upbeat on Novartis Key Pipeline Assets' Probability of Success; Price Objective Up	MT
03-20	NOVARTIS AG : Barclays remains Neutral	ZD
03-20	NOVARTIS AG : Goldman Sachs keeps a Sell rating	ZD
03-10	Swiss stocks - Factors to watch on March 10	RE
03-09	Berenberg Notes Novartis 'Fully Valued' After FY25 Report Review; Price Target Up	MT
03-06	Berenberg Raises Price Target on Novartis to $141 From $116, Keeps Hold Rating	MT
03-06	NOVARTIS AG : Berenberg remains Neutral	ZD